» Articles » PMID: 17942897

Autophagy is Activated in Colorectal Cancer Cells and Contributes to the Tolerance to Nutrient Deprivation

Overview
Journal Cancer Res
Specialty Oncology
Date 2007 Oct 19
PMID 17942897
Citations 161
Authors
Affiliations
Soon will be listed here.
Abstract

Several types of cancer cells, including colorectal cancer-derived cell lines, show austerity, the resistance to nutrient starvation, but exactly how cancer cells obtain energy sources under conditions in which their external nutrient supply is extremely limited remains to be clarified. Because autophagy is a catabolic process by which cells supply amino acids from self-digested organelles, cancer cells are likely to use autophagy to obtain amino acids as alternative energy sources. Amino acid deprivation-induced autophagy was assessed in DLD-1 and other colorectal cancer-derived cell lines. The autophagosome-incorporated LC3-II protein level increased after treatment with a combination of autolysosome inhibitors, which interferes with the consumption of autophagosomes. Autophagosome formation was also morphologically confirmed using ectopically expressed green fluorescent protein-LC3 fusion proteins in DLD-1 and SW480 cells. These data suggest that autophagosomes were actively produced and promptly consumed in colorectal cancer cells under nutrient starvation. Autolysosome inhibitors and 3-methyl adenine, which suppresses autophagosome formation, remarkably enhanced apoptosis under amino acid-deprived and glucose-deprived condition. Similar results were obtained in the cells with decreased ATG7 level by the RNA interference. These data suggest that autophagy is pivotal for the survival of colorectal cancer cells that have acquired austerity. Furthermore, autophagosome formation was seen only in the tumor cells but not in the adjacent noncancerous epithelial cells of colorectal cancer specimens. Taken together, autophagy is activated in colorectal cancers in vitro and in vivo, and autophagy may contribute to the survival of the cancer cells in their microenvironment.

Citing Articles

Autophagy-related protein LC3β and its association with clinical-pathological characteristics, mismatch repair proteins and survival in colorectal carcinoma.

Gakinya S, Nzioka A, Mugo A, Onyuma T, Ogutu J Front Med (Lausanne). 2025; 12:1512127.

PMID: 40018347 PMC: 11865083. DOI: 10.3389/fmed.2025.1512127.


Cancer stem cell populations are resistant to 5-aminolevulinic acid-photodynamic therapy (5-ALA-PDT).

Rice C, Chelakkot V, Conohan N, Hirasawa K Sci Rep. 2025; 15(1):4367.

PMID: 39910203 PMC: 11799205. DOI: 10.1038/s41598-025-88173-3.


Autophagy and cancer therapy.

Pimentel J, Zhou J, Wu G Cancer Lett. 2024; 605:217285.

PMID: 39395780 PMC: 11665950. DOI: 10.1016/j.canlet.2024.217285.


Importance of Autophagy Regulation in Glioblastoma with Temozolomide Resistance.

Hwang Y, Lee D, Lee E, Oh J Cells. 2024; 13(16.

PMID: 39195222 PMC: 11353125. DOI: 10.3390/cells13161332.


SPHK1 potentiates colorectal cancer progression and metastasis via regulating autophagy mediated by TRAF6-induced ULK1 ubiquitination.

Chen D, Wu J, Qiu X, Luo S, Huang S, Wei E Cancer Gene Ther. 2023; 31(3):410-419.

PMID: 38135696 PMC: 10940154. DOI: 10.1038/s41417-023-00711-1.